A case of bone marrow carcinosis from gastric cancer that presented hypocalcemia caused by zoledronic acid during the treatment of methotrexate/5-fluorouracil sequential therapy

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 3, 2009, Pages 489-492

  Tsukasa, Koichiro ^a   Fujimoto, Chinatsu ^a   Ariyama, Hiroshi ^a   Esaki, Taito ^a   Murakawa, Masahiro ^b   Syoji, Tetsuya ^b   Baba, Eishi ^b   Hiranuma, Seiichi ^c  

^a National Hospital Organization   (Japan)

^b Kaizuka Hospital   (Japan)

^c Hiranuma Orthopedic Hospital   (Japan)

Author keywords

Bone marrow carcinosis; Hypocalcemia; Zoledronic acid

Indexed keywords

FLUOROURACIL; GLUCONATE CALCIUM; METHOTREXATE; PACLITAXEL; TUMOR MARKER; ZOLEDRONIC ACID;

ADULT; ANOREXIA; ARTICLE; BONE DISEASE; BONE MARROW CARCINOSIS; BRAIN METASTASIS; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CARCINOMATOSIS; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; FATIGUE; HUMAN; HYPOCALCEMIA; LOW BACK PAIN; LYMPH NODE METASTASIS; MALE; PROGNOSIS; RELAPSE; STOMACH CANCER; TREATMENT OUTCOME;

EID: 79959813034     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584-593, 2002.
2. Tanvetyanon T and Stiff PJ: Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 17(6):897-907, 2006. (Pubitemid 43785797)
3. Peter R, Mishra V and Fraser WD: Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ 328(7435):335-336, 2004. (Pubitemid 38197856)